Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Multiple Myeloma × Clinical Protocols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1 Locally Advanced Breast Cancer 1 Leukemia, Myeloid, Acute 1 Endometrial Neoplasms 1

Interventions

Dexamethasone 49 Cyclophosphamide 35 Bortezomib 26 Melphalan 20 Lenalidomide 17 Thalidomide 14 pomalidomide 13 fludarabine 9 daratumumab 8 carfilzomib 7 Filgrastim 7 Doxorubicin 6 Busulfan 6 Prednisone 5 Peripheral Blood Stem Cell Transplantation 5 Surveys and Questionnaires 4 Mycophenolic Acid 4 Clarithromycin 4 Bendamustine Hydrochloride 4 selinexor 3 sargramostim 3 ixazomib 3 isatuximab 3 fludarabine phosphate 3 Radiotherapy 3 Neoadjuvant Therapy 3 Methylprednisolone 3 Interferon-alpha 3 Idarubicin 3 Etoposide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01554852 2018-06-11

Myeloma XI

University of Leeds

Phase 3 Unknown

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡